As cellular therapy products often cross international borders, it is important to be aware of applicable regulations in other regions. Products shipped across international borders must meet regulatory requirements of the competent authority of the exporting and importing country. Information on some non-U.S. competent authorities can be accessed via the links provided below. The information for each country is meant to serve as a resource, not a substitute for regulatory information or legal advice. Additionally, the information on this page is not updated in real-time, please contact the relevant competent authority to receive the most up-to-date information.
New Biotherapies Supplement Now Available From Transfusion
October 02, 2026
New AABB Publication Explores Cellular Therapy Scenarios
September 29, 2026
Reminder: Comments on Proposed 13th Edition of Standards for Biotherapy Services Due Oct. 13
September 29, 2026